Trading Century
  • Trading News
  • Economy
  • Editor’s Pick
  • Finance
  • Investing
  • Politics
  • Stock
  • About Us
  • Privacy Policy
  • Terms & Conditions
  • Email Whitelisting
  • Contact
Subscribe
Trading Century
Trading Century
  • Trading News
  • Economy
  • Editor’s Pick
  • Finance
  • Investing
  • Politics
  • Stock
  • Politics
  • Stock
  • Trading News

Pharmally officials freed after almost 7 months in jail

  • June 2, 2022

TWO officials of a company that allegedly sold overpriced medical supplies to the government were released from the Pasay City jail on Thursday after almost seven months.

The Senate sergeant-at-arms released Pharmally Pharmaceutical Corp. Director Linconn Ong and Corporate Secretary Mohit Dargani after Senate President Vicente C. Sotto III signed their release order on Wednesday evening, when Congress adjourned sine die, the Senate said in a statement.

At a hearing last year, the Senate blue ribbon committee asked the officias to submit documents on Pharmally’s dealings with the Budget department’s procurement service. They were cited in contempt and sent to jail after failing to produce the files.

“They have no one but themselves to blame for their continuing detention in the same manner that only their action, their compliance with just directives can pave the way for their release,” Senator Richard J. Gordon, Sr., who heads the committee, said earlier.  

Mr. Gordon has presented a draft report on the body’s findings after its probe of multibillion coronavirus pandemic contracts. Only nine senators have signed the committee report, short of the 11 needed for it to be discussed in plenary.

“There is so much ballyhoo,” Mr. Gordon said in a statement. “Why create a blue ribbon committee if the Senate members will not vote?”

Senate Majority Leader Juan Miguel F. Zubiri and Senator Sherwin T. Gatchalian have said they would only sign the committee report if allegations against outgoing President Rodrigo R. Duterte were removed.

Mr. Gordon’s committee in a 113-page report said Mr. Duterte could be held accountable for siding with people involved in the deals.

It also endorsed charges against Health Secretary Francisco T. Duque III, Budget Director Warren Rex Liong, former Budget Undersecretary Lloyd Christopher Lao, former Duterte economic adviser Michael Yang and several Pharmally officials.

Senator Ana Theresia N. Hontiveros-Baraquel has said she would seek a reinvestigation in the next Congress if the report is not discussed in plenary. The body held 18 hearings over seven months. — Alyssa Nicole O. Tan

Previous Article
  • Politics
  • Stock
  • Trading News

Warriors offense battles rugged Celtics defense in NBA Finals

  • June 2, 2022
View Post
Next Article
  • Politics
  • Stock
  • Trading News

China spurns DFA protest against annual fishing ban

  • June 2, 2022
View Post
You May Also Like
View Post
  • Trading News

Waller Offers Common Sense View on Financial Risks of Climate Change

  • May 29, 2023
View Post
  • Trading News

Ga. Reps Slice Possible Lifeline for Kids in Failing Schools

  • April 5, 2023
View Post
  • Trading News

Silicon Valley Bank: Mismanagement Is Not an Excuse for Inefficient Regulation

  • April 3, 2023
View Post
  • Trading News

Fetterman released from inpatient treatment for depression

  • April 1, 2023
View Post
  • Trading News

Fetterman released from inpatient treatment for depression

  • April 1, 2023
View Post
  • Trading News

Fetterman released from inpatient treatment for depression

  • April 1, 2023
View Post
  • Trading News

Fetterman released from inpatient treatment for depression

  • April 1, 2023
View Post
  • Trading News

Fetterman released from inpatient treatment for depression

  • April 1, 2023
Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.


    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



    If you want to delve into the USA business updates and investors daily routine,
    go to our partner project Daily Business Investor.

    TradingCentury.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.

    Copyright © 2023 Trading Century. All Rights Reserved.

    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • About Us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting
    • Contact
    Trading Century
    Your daily news source covering investing ideas, market stocks, business, retirement tips from Wall St. to Silicon Valley.

    Input your search keywords and press Enter.